Ni, Jun
Chen, Huisheng
Chen, Guofang
Ji, Yong
Yi, Fei
Zhang, Zhuobo
Yang, Yi
Wu, Jin
Cai, Xueli
Shao, Bei
Wang, Jianfeng
Liu, Yafang
Geng, Deqin
Qu, Xinhui
Li, Xiaohong
Wei, Yan
Ding, Jianping
Lü, Hua
Huang, Yining
Huang, Yonghua
Xiao, Bo
Gong, Tao
Cui, Liying http://orcid.org/0000-0001-6342-7835
Wang, Dong
Han, Shugen
Gao, Xiaoping
Zhuang, Xiaorong
Tan, Guojun
Zhu, Runxiu
Bi, Hongye
Yang, Hong
Deng, Youqing
Zhou, Jinghua
Zheng, Shengzhe
Wang, Zhiyong
Lu, Xiaodong
Li, Juntao
Huang, Lina
Hu, Weimin
Zang, Dawei
Yao, Xiaoxi
Li, Li
Zhao, Liandong
Li, Luoqing
Wang, Shifang
Ke, Kaifu
Lu, Tianming
Ma, Qilin
Zhang, Qing
Wang, Baojun
Zhao, Liang
Dong, Hongliang
Gao, Wei
Liu, Ying
Tang, Yamei
Gao, Junfeng
Yu, Xiaofei
Guo, Libin
Lin, Haiyan
Wei, Xiue
Tian, Chenglin
Zhang, Tong
Li, Yaguo
Wen, Guoqiang
Zhou, Chengfang
Fang, Qi
,
Funding for this research was provided by:
Peking Sihuan Pharmaceutical Group
Article History
Received: 14 February 2020
Accepted: 26 June 2020
First Online: 14 July 2020
Ethics approval and consent to participate
: This study was conducted in accordance with the ethical guidelines for human medical research as stated in the Declaration of Helsinki (2013). In addition, this study was conducted in accordance with the ethical principles of the Chinese Good Clinical Practice for Drug Administration. All patients provided voluntary written informed consent prior to commencing any study procedures. The ethics committees of all 72 research institutes reviewed and approved the study protocol (see Table 4 in InternalRef removed for committee names and reference numbers).
: Not applicable.
: Yong Ji is an Associate Editor and an editorial board member of BMC Neurology. All other authors (J. Ni, H. Chen, G. Chen, F. Yi, Z. Zhang, Y. Yang, J. Wu, X. Cai, B. Shao, J. Wang, Y. Liu, D. Geng, X. Qu, X. Li, Y. Wei, J. Ding, H. Lü, Y. Huang, Y. Huang, B. Xiao, T. Gong, L. Cui) declare that they have no competing interests.